Company Filing History:
Years Active: 2025
Title: Yanfei Wang: Innovator in Elastase Inhibitor Prodrugs
Introduction
Yanfei Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of elastase inhibitor prodrugs. His innovative work aims to enhance the efficacy of treatments related to pulmonary conditions.
Latest Patents
Yanfei Wang holds a patent for an elastase inhibitor prodrug, which is a compound designed to improve the pharmacokinetics of active compounds in the lungs. The patent details a compound of formula I or its pharmaceutically acceptable salt, ester, isomer, or solvate. Compared to the control example in WO 2018/175173 A1, his compound demonstrates high pulmonary exposure and a long half-life. The prodrugs significantly increase the concentration and residence time of the active compound in the lungs, showcasing substantial improvements in pharmacokinetics in vivo.
Career Highlights
Yanfei Wang is currently associated with Suzhou Ark Biopharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in creating more effective treatments for respiratory diseases.
Collaborations
He collaborates with talented colleagues, including Cheng Peng and Yang Zhou, who contribute to the innovative environment at Suzhou Ark Biopharmaceutical Co., Ltd.
Conclusion
Yanfei Wang's contributions to elastase inhibitor prodrugs represent a significant advancement in pharmaceutical innovation. His work not only enhances treatment options but also demonstrates the potential for improved patient outcomes in respiratory health.